| Authors: |
di Lillo A; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; ThermoFisher Scientific-mRNA Department, Monza, Italy., Tavella S; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Institute of Molecular Genetics (IGM), National Research Institute (CNR), Pavia, Italy., Iannelli F; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Division of Hematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy., Crisafulli G; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy., Gioia U; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Institute of Molecular Genetics (IGM), National Research Institute (CNR), Pavia, Italy., Trastus LA; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy., Cabrini M; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; JoVE, Cambridge, MA, USA., d'Adda di Fagagna F; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy. fabrizio.dadda@ifom.eu.; Institute of Molecular Genetics (IGM), National Research Institute (CNR), Pavia, Italy. fabrizio.dadda@ifom.eu. |